News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleStudy Finds Higher Risk for Fracture From Falls in Men Than in Women
March 12, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Health Professionals and Laypeople Feel Differently About Allocating Scarce Lifesaving Resources in a Crisis
March 12, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Sugar Compound’s Key Role in SARS-CoV-2 Infection May Lead to New COVID-19 Therapies
March 11, 2024 - NCATS News
A research team led by NCATS scientists found new clues about how SARS-CoV-2, the virus that causes COVID-19, can infect cells. This could lead to new treatments to block viral infection.
Sharing Science and Stories at Rare Disease Day Symposium
March 7, 2024 - Grantee/Partner News
- Our Impact on Rare Diseases
P.J. Brooks, Ph.D., on Working to Bring Gene Therapy Development to More Neuromuscular Disorders
March 5, 2024 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
UPMC Receives $7.8 Million Grant for New Drug Discovery Center
March 5, 2024 - Grantee/Partner News
- Tissue Chip for Drug Screening